Action LABSTYLE INNOVATIONS CORP
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués LabStyle Innovations Corp Nasdaq

Actions

US50544T3023

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer
PR
DarioHealth Reports First Quarter 2024 Financial and Operating Results
PR
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th
PR
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
PR
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
PR
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
PR
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH
AQ
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
PR
DarioHealth : Q4 and full year 2023 earnings call transcript
PU
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
PR
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
PR
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
PR
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
PR
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions
PR
REGIONAL UNION SELECTS DARIO'S CARDIOMETABOLIC SOLUTION FOR DIABETES, HYPERTENSION, WEIGHT MANAGEMENT AND GLP-1 SUPPORT
AQ
Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support
PR
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health
PR
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
PR
Dario Contracts with New Employer for Cardiometabolic Solution
PR
DARIOHEALTH CORP. - NEW RESEARCH SHEDS LIGHT ON MEDIATORS OF IMPROVED OUTCOMES IN DARIO USERS
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DRIO
  4. Action
  5. Actualités LabStyle Innovations Corp
  6. Communiqués